Abstract In the present study, we aimed to report the individual sex-different genetic markers across autosomes in European-and African-origin populations. A total of 8400 females and 8081 males in 19 independent cohorts were genotyped across genomes using Illumina or Affymetrix arrays. The allele frequencies were compared between females and males in nine non-clean cohorts (with some human disease traits) using genome-wide logistic regression and then the nominally significant associations were replicated across 10 clean cohorts (without disease traits). Meta-analysis was performed to derive the combined p values across all cohorts. We found 13 markers that were genome-wide significant (p B 5 9 10 -8 ) between females and males in the meta-analysis of all cohorts of European descent, including rs7740449 at SYNE1, rs7531151 at PLD5, rs697455 at PPP1R12B, rs6745746 at LOC100128413, rs17000079 at PARM1, rs11948070 at PDE4D, rs7801825 at INSIG1, rs9551642 at MTUS2, rs2932174 at TPTE2, rs1961597 at SALL3, rs4117529 at METTL4, rs6021473 at SALL4 and rs6092466 at RAE1, and one marker, i.e., rs10145208 at PCNX, that was genomewide significant in the meta-analysis of all cohorts of African descent. The most robust finding was rs7740449 at SYNE1, next to ESR1. We conclude that there are many sex-different markers on autosomes. These markers may be informative in differentiating females and males.
Introduction
Growing numbers of studies report that outcomes in human health are sex-sensitive; that is, they are stronger for either males or females; others are sex-specific; that is, they apply only to males or to females; and others are opposite in males and females. These sex-differences have been widely demonstrated by human and animal pharmacokinetic studies (Zhu et al. 2007 ), pharmacogenetic studies (Wang and Huang 2007) , behavioral studies (Keeley et al. 2013) , and neuroimaging studies (Cahill 2014) . Nevertheless, many gaps remain in our understanding of these sex-differences. It is hypothesized that genetic factors contribute to these biological sex-differences.
The most straightforward difference in genomes between females and males resides in the sex chromosomes; that is, males have Y chromosomes but females do not. The Y-specific genes on Y chromosome determine the male-specific characters. For example, the sex-determining region Y gene (SRY) in an ampliconic region on Y chromosome is a testis-determining gene. In addition to the Y-specific genes, there are also many genes on Y chromosome that are homogenous to their counterparts on X chromosome. For example, genes in the pseudoautosomal regions (PARs) on Y chromosome are identical (*100 %) to the corresponding PARs on X chromosome; genes in the X-transposed regions (XTRs) on Yp11.2 is 99 % identical to the genes on Xq21.3; and genes in the X-degenerate regions (XDRs) on Y are 60-96 % identical to their counterparts on X (reviewed by Zuo et al. 2013b) . Although these genes are homogenous between X and Y chromosomes, their genotype frequency distributions are still significantly different between males and females. For example, AMELY in an XDR on Y chromosome has been used for gender determination of forensic DNA (Pouchkarev et al. 1998 ). These homogenous genes may be associated with the traits that exist in both sexes but are significantly different between females and males. For example, the NLGN4Y in an XDR on Y chromosome has been related to autism that has a higher prevalence (4:1) in males than females (Jamain et al. 2003) .
Sex at birth depends on whether the sperm bears a Y chromosome. Whether a Y-bearing sperm fertilizes an egg depends on the development, motility and survival time of this sperm and more other complicated environmental factors. However, the development, motility and survival time of a sperm might not be necessary to be regulated only by the proteins encoded by genes on sex chromosomes, but possibly also by genes on autosomes. The genetic variants both on autosomes and sex chromosomes can influence natural fertility in humans (Kosova et al. 2010) . Furthermore, some loci on sex chromosomes were transposed from autosomes during primate evolution (Saxena et al. 1996) ; X-autosome or Y-autosome translocations may occur frequently during recombination (Pabst et al. 2002) ; and some genes on autosomes, e.g., estrogen receptor 1 gene (ESR1) on 6q25.1, are related to the function of sexrelated hormones or intrauterine or postnatal hormonal influences. Most of the Sex Determining Region Y-Box (SOX) genes are located on autosomes, e.g., SOX9 on 17q23. Therefore, theoretically, it is likely that some genes on autosomes might also be significantly different between two sexes. However, this is rarely investigated until recently (Boraska et al. 2012) . In the present study, we scanned the whole autosomes with a large sample size, to report the individual sex-different genetic markers across autosomes.
Materials and methods

Subjects
A total of 16,481 European-or African-origin subjects from 12 studies were included. Demographic data including dbGaP access numbers are presented in Table 1 . They were selected because they were available to us for a previous study on neuropsychiatric diseases (Zuo et al. 2013a ). These subjects were separated into 19 independent cohorts for analysis based on their ascertainments. Among them, seven independent cohorts with European descent and two independent cohorts with African descent were non-clean, each with a diagnosis of one neuropsychiatric disease such as Parkinson's disease, schizophrenia, bipolar disorder, Alzheimer's disease or ALS; eight independent cohorts with European descent and two independent cohorts with African descent were clean, without these diseases. Subjects of European descent included Caucasians, European-Americans, Italians and Canadians, and subjects with African descent were African-Americans. 8400 subjects were females and 8081 were males. All selfreported sex information was confirmed using genetic markers in AMELX/Y gene in an X-degenerate region (XDR) on X and Y chromosomes. All unmatched sexes were discarded. The age distributions generally matched between females and males within each cohort.
Genotyping
The subjects were genotyped using Illumina or Affymetrix microarrays with 250,000 to 1 million of SNPs. Illumina platforms included HumanCNV370v1 (for cohorts #2 and #12), HumanHap550v3.0 (for cohorts #1, #7, #8, #9 and #15), and Human_1 M (for cohort #13). Affymetrix platforms included Mapping250K_Nsp/Sty (for cohorts #6 and #14) and AFFY_6.0 (1.8 M) (for cohorts #3, #4, #5, #10, #11, #16, #17, #18 and #19) ( Table 1) .
Data cleaning
Before association analysis was conducted, we stringently cleaned the phenotype and genotype data within each cohort. Excluded were subjects with poor genotypic data and questionable diagnostic information, subjects with allele discordance, duplicated IDs, potential sample misidentification, sample relatedness, sample misspecification, gender anomalies, chromosome anomalies (such as aneuploidy and mosaic cell populations), missing race, non-European and non-African ethnicity, population group outliers, subjects with a mismatch between self-identified and genetically-inferred ethnicity, and subjects with a missing genotype call rate C2 % across all SNPs. Furthermore, we filtered out the monomorphic SNPs and the SNPs with allele discordance, chromosomal anomalies, batch effect, Mendelian errors (in family samples), an overall missing genotype call rate C2 %, and MAFs\0.01. The SNPs that deviated from Hardy-Weinberg Equilibrium (HWE) (p \ 10 -4 ) both in males and females within each cohort were excluded. Finally, the autosomal SNPs that map to multiple genomic regions were also excluded, e.g., rs55755291 on chromosomes 1, 2, 3, and X. Many technical issues such as strand flipping have also been carefully solved before association analysis. The cleaned sample sizes and SNP sizes are listed in Table 1 .
Genome-wide association analysis
The allele frequencies were compared between females and males in the target cohorts using logistic regression as implemented in the program PLINK (Purcell et al. 2007 ). Sex status served as the dependent variable, alleles served as the independent variables, and ancestry proportions served as the covariates. The ancestry proportions for each individual were estimated by integrating the ancestry information content of 6436 independent ancestry-informative SNPs using the program STRUCTURE (Pritchard et al. 2000) . Each of these 6436 SNPs had significant difference in allele frequency between Europeans and Africans (p \ 10 -8 ), and was in HWE (p [ 0.05) in each cohort. They were not associated with any disease examined (p [ 0.05) and were not correlated (D 0 = 0). The selection procedure for these 6436 SNPs was detailed elsewhere (Zuo et al. 2012) . Ancestry proportions as covariates were included in the regression model to control for population stratification and admixture effects.
Study design and data analytic strategy
(1) Subjects with European descent and African descent are heterogeneous. Allele frequency distributions were quite different between these two populations. Thus, all association analysis and meta-analysis were performed within the same ethnicity, i.e., separately in Europeans and Africans.
(2) The three Illumina platforms are different in SNP density but completely overlap. After imputation using the same reference panels (i.e., 1000 Genome project and HapMap 3), these three platforms were highly consistent in marker sets and thus were analyzed together in metaanalysis. The two Affymetrix platforms are different in SNP density and partially overlap. After imputation, the marker set consistency increased but was still not high (\60 %), thus these two platforms were separately metaanalyzed first, and then jointly meta-analyzed to detect more informative markers. (3) We performed genome-wide association analysis on sex difference in each non-clean cohort first. Next, we extracted those replicable associations that were nominally significant (p \ 0.05) across all non-clean cohorts. We meta-analyzed these replicable associations to drive the first global p 1 value and only the associations with global p 1 \ 10 -3 in meta-analysis were retained for further analysis. Then, to extract those associations that were independent of the disease status, we replicated these replicable associations (with p 1 \ 10 -3 ) in the clean cohorts. Only those associations nominally significant (p \ 0.05) across all clean cohorts were retained. Finally, these replicated associations were meta-analyzed across all non-clean and clean cohorts to derive the second p 2 values. Only those associations with p 2 \ 5 9 10 -8
were treated as genome-wide significant ones and presented in Tables.
Meta-analysis
Meta-analysis was performed to derive the combined p values across cohorts using the program METAL (Willer et al. 2010 ). An overall z-statistic and a p value for each SNP were calculated from a weighted sum of the individual statistics. Weights were proportional to the square-root of the number of individuals examined in each sample and selected such that the squared weights sum to 1.0. Metaanalysis was conducted across non-clean cohorts to derive the first p 1 value, then across all cohorts including nonclean and clean ones to derive the second p 2 value. The genome-wide Bonferroni-corrected a for p 2 was set at 5 9 10 -8 (by one million markers).
Prediction of sex by sex-different markers
The cumulative Positive Predictive Values (PV ? ) and the cumulative Positive Likelihood Ratios (LR ? ) of the significant sex-different alleles were calculated using Baye-
A i jT , where P is probability; A i is the ith independent contributory allele; T is the trait, i.e., female or male; T is male or female; n is the number of independent alleles; and \ denotes the Intersection approach.
Results
We checked and confirmed the quality of the association analysis results first.
(1) QQ plots showed that the population stratification effects in the association findings in all cohorts had already been successfully controlled (|ks| \ 1.1). (2) Discussion) . These pieces of evidence demonstrated that our data had high quality for association analysis. However, due to the heterogeneity of genotyping platforms, not every genetic marker was fully genotyped across all cohorts even after imputation, which is a limitation of the present study. After quality check, we found some significant sex-allele associations. The frequencies of minor allele T of rs7740449 at SYNE1 (Spectrin Repeat Containing, Nuclear Envelope one gene) on Chr6 were 0.305-0.321 in female non-clean subjects and 0.406-0.522 in male non-clean subjects in three independent cohorts of European descent with Parkinson disease or amyotrophic lateral sclerosis (ALS). They all were nominally significantly different between females and males in these three cohorts [odd ratio (OR): 0.43-0.64; 1.1 9 10 -5 B p B 2.7 9 10 -4 ]. The genotype frequency distributions were in significant Hardy-Weinberg Disequilibrium (HWD) in females in all of the three cohorts (2.5 9 10 -9 B p B 0.015), but in Hardy-Weinberg Equilibrium (HWE) in males (p [ 0.05). Meta-analysis of these three cohorts derived a combined p 1 = 2.9 9 10 -10 (Z = -7.06). Furthermore, the allele frequencies of this allele in other five independent clean cohorts of European descent [minor allele frequencies (MAFs) = 0.289-0.342 in females and 0.357-0.471 in males] were similar to the above three non-clean cohorts. They were also nominally significantly different between females and males (3.8 9 10 -6 B p B 0.029) in these five clean cohorts (OR: 0.58-0.80). The genotype frequency distributions were in significant HWD in females in four cohorts (4.6 9 10 -13 B p B 1.3 9 10 -3 ) and in suggestive HWD in females in the 5th cohort (p = 0.057), but in HWE in males in all cohorts (p [ 0.05). Meta-analysis of all of these eight European cohorts derived a combined p 2 = 8.2 9 10 -22 (Z = -9.60) ( Table 2) . ks from QQ plots for these eight cohorts were 0.99-1.07 (plots not shown). Other 11 cohorts we analyzed were not genotyped on this SNP, so they were not included in the metaanalysis.
Rs10145208 at PCNX (Pecanex Homolog gene) on Chr14 was only genotyped in the four cohorts of African descent. The frequencies of minor allele T of rs10145208 were similar across these four cohorts in disregard of their disease status. They were 0.020-0.025 in females and 0.039-0.063 in males. They were nominally significantly different between females and males (OR: 0.31-0.41; 6.5 9 10 -5 B p B 2.9 9 10 -4 ) in three cohorts. They were not significantly different in the fourth cohort (#17), probably because of the small sample size of males of this cohort. The genotype frequency distributions were in HWE in both females and males in all of the four cohorts (p [ 0.05). Meta-analysis of these four cohorts derived a combined p 2 = 7.5 9 10 -11 (Z = -6.51) ( Table 3) . ks from QQ plots for these four cohorts were 1.04-1.09 (plots not shown).
We found 12 SNPs that were significantly different between females and males in the meta-analysis of two Canadian cohorts (#6 and #14). They were rs7531151 at PLD5 (Phospholipase D Family, Member 5 gene) (p = 3.2 9 10 -43 ) and rs697455 at PPP1R12B (Protein Phosphatase 1, Regulatory Subunit 12B gene) (p = 1.8 9 10 -8 ) on Chr1, rs6745746 at LOC100128413 on Chr2 (p = 4.0 9 10 -13 ), rs17000079 at PARM1 (Prostate Androgen-Regulated Mucin-Like Protein 1 gene) on Chr4 (p = 6.9 9 10 -13 ), rs11948070 at PDE4D (CAMPSpecific Phosphodiesterase 4D gene) on Chr5 (p = 4.5 9 10 -15 ), rs7801825 at INSIG1 (Insulin Induced Gene 1 gene) on Chr7 (p = 3.7 9 10 -9 ), rs9551642 at MTUS2 (Microtubule Associated Tumor Suppressor Candidate 2 gene) (p = 4.6 9 10 -9 ) and rs2932174 at TPTE2 (Transmembrane Phosphoinositide 3-Phosphatase And Tensin Homolog 2 gene) (p = 4.4 9 10 -9 ) on Chr13, rs1961597 at SALL3 (Spalt-Like Transcription Factor 3 gene) (p = 6.8 9 10 -10 ) and rs4117529 at METTL4 (Methyltransferase Like 4 gene) (p = 1.5 9 10 -8 ) on Chr18, rs6021473 at SALL4 (Spalt-Like Transcription Factor 4 gene) (p = 1.3 9 10 -17 ) and rs6092466 at RAE1 (Ribonucleic Acid Export 1 gene) (p = 6.3 9 10 -9 ) on Chr20. The minor allele frequencies of these markers were similar between the two cohorts, regardless of disease status. They all were significantly different between females and males (4.2 9 10 -23 B p B 2.5 9 10 -3 ) in these two cohorts. The genotype frequency distributions of rs7531151, rs6745746, rs17000079 and rs9551642 were in significant HWD in females in the two cohorts (5.8 9 10 -18 B p B 5.5 9 10 -3 ) but in HWE in males; the other markers were all in HWE in both females and males (p [ 0.05). The frequencies of the minor allele A of rs7531151 were equal or close to 0 in males, but larger than 10 % in females; it was a female-specific allele (Table 4 ). Both ks from QQ plots were 1.02 for these two cohorts (Fig. 1) . These markers were not genotyped in the other 17 cohorts.
The cumulative Positive Predictive Values (PV ? ) of alleles T-A-G-G-G-A-A-A-C-A-A-G of rs7740449-rs6974 55-rs6745746-rs17000079-rs11948070-rs7801825-rs95516 42-rs2932174-rs1961597-rs4117529-rs6021473-rs6092466, which were dominant in European males at genome-wide significance level (Tables 2, 4 ? of allele A of rs7531151, which was dominant in European females, was close to 1.000. The PV ? of allele T of rs10145208, which was dominant in African males at genome-wide significance level ( 
Discussion
In the present study, we found 14 markers that were significantly different between females and males at genomewide significance level in meta-analysis; among them, 13 were genome-wide significant in Europeans and one in Africans. All of these markers were not significantly associated with any disease examined. The allele frequen- N sample size, OR/Z odd ratios or z-scores (meta), Non-clean with one disease, HWE Hardy-Weinberg equilibrium Table 4 Sex difference in Canadian cohorts 
HWE (F), Hardy-Weinberg Equilibrium in females
Genes Genom (2015 Genom ( ) 37:1007 Genom ( -1016 Genom ( 1013 cies and the association findings for these markers were replicable across at least two independent cohorts. The most robust finding was rs7740449 at SYNE1 on Chr6, next to ESR1. The allele frequencies of this marker were highly consistent across eight independent cohorts of European descent genotyped on different platforms. Its associations with sex were highly replicable across eight cohorts with highly similar OR values and the same OR direction. The genotype distributions of this marker were in significant HWD in females across all eight cohorts, which made the HWD impossible to be attributed to systematic genotyping errors or chance (see Supplementary Discussion). The second most robust finding was rs10145208 at PCNX on Chr14 in Africans because of the similar reasons to rs7740449. The third most robust findings were those 12 SNPs in Canadian cohorts; among which, allele A of rs7531151 at PLD5 was a female-specific allele. An individual of European descent carrying alleles T-A-G-G-G-A-A-A-C-A-A-G of rs7740449-rs697455-rs6745746-rs17000 079-rs11948070-rs7801825-rs9551642-rs2932174-rs19615 97-rs4117529-rs6021473-rs6092466 had 98.3 % of probability to be male but only 1.7 % to be female. An individual of European descent carrying alleles C-G-A-A-C-G-T-C-G-G-G-C of these 12 markers had 99.9 % of probability to be female but only 0.1 % to be male. An individual of European descent carrying allele A of rs7531151 had approximately 100 % of probability to be female. An individual of African descent carrying allele T of rs10145208 had 73.3 % of probability to be male but only 26.7 % to be female. These markers may provide helpful informative content for differentiating females and males in the presence of DNA in the specimen as the Y-specific signal does. They may also provide a direction for the investigation on sex-different traits. For example, alcoholism and autism are sex-different diseases in prevalence; they might be associated with these sex-specific markers, which is worthy of future investigation. The frequency of major allele C of rs7740449 at SYNE1 in females was about 0.05-0.20 higher than males of European descent. This marker was in significant HWD in females in all cohorts examined. The minor allele frequency of rs10145208 at PCNX in males was about 1.6-3.2 times of that in females of African descent. The minor allele frequencies of rs697455 at PPP1R12B, rs6745746 at LOC100128413, rs17000079 at PARM1, rs11948070 at PDE4D, rs9551642 at MTUS2, and rs2932174 at TPTE2, rs1961597 at SALL3 and rs6092466 at RAE1 in Canadian females were about 1.7-7.6 times of those in Canadian males. The minor allele frequencies of rs7801825 at INSIG1, rs4117529 at METTL4 and rs6021473 at SALL4 in Canadian males were about 2.0-3.2 times of those in Canadian females. The minor allele A of rs7531151 at PLD5 was female-specific in Canadians. Among these markers, rs6745746 at LOC100128413, rs17000079 at PARM1, rs9551642 at MTUS2, and rs7531151 at PLD5 were in significant HWD in females in both Canadian cohorts. A female-associated allele of a SNP in females should be present at a higher rate than the general population (a natural selection), which may violate HWE of that SNP in females, as observed for the major allele C of rs7740449 and the minor alleles of several other markers. Thus, HWD of a SNP in females could be an indicator of an allele-female association and a possible recessive inheritance mode (Luo et al. 2008 ) (see Supplementary Discussion). The female-specific alleles of these 5 SNPs may contribute to female-specific traits. Other 9 SNPs were in HWE in both females and males. Their alleles may contribute to sex-different traits. Six of the above proteincoding genes including SYNE1, PPP1R12B, PDE4D, TPTE2, RAE1 and PLD5 are related to phosphorylation and two genes including LOC100128413 and PARM1 are related to apoptosis. Both protein phosphorylation and apoptosis are important physiological processes involving in the development, motility and survival time of X-bearing and Y-bearing sperm (Chan et al. 2009; Navara 2010) . They have been reported to contribute to the gender-difference of many traits (Lagranha et al. 2010; Siegel et al. 2011) . Furthermore, one gene (PARM1) is androgen-related gene; one gene (PDE4D) is next to the androgenrelated gene PART1; and other two genes (SYNE1 and TPTE2) are next to estrogen-related genes, consistent with their roles in sex-difference. Finally, the major limitation of this study is that many markers were not consistently genotyped across all cohorts, which might result in information loss. More sex-different markers are anticipated to be identified if using denser and more consistent marker sets.
Identifying and understanding sex differences can improve our understanding of the nature and etiology of human diseases and have implications for tailoring prevention and treatment interventions to maximize outcomes for both males and females. Despite some important progresses have been made in laboratory sex-based research and the present study also contributes to these progresses, it is in an early stage in this field. More potential biological mechanisms leading to sex-difference of markers on autosomes and the biological implications of these markers in human health are warranted by future investigations.
We conclude that there are many sex-different markers on autosomes. These markers may provide an alternative approach to differentiate females and males in the absence of sex chromosomes.
